NDC 0781-5422-06 - Pioglitazone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-5422
- Requested NDC
- 0781-5422-06
- Package NDCs from labels
- 0781-5422-06, 0781-5422-64, 0781-5422-31, 0781-5422-92, 0781-5422-10
- Manufacturer
- Sandoz Inc
- Effective date
- 2018-06-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pioglitazone - Sandoz Inc | Sandoz Inc | 2018-06-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-5422-10 | EA - Each | 0781-5422 | c8f73a0b-6cc7-435b-a173-b5b5da133610 | 1 | 2013-03-03 |
| 0781-5422-31 | EA - Each | 0781-5422 | f0257dae-38c8-46d5-96a9-647982370d48 | 1 | 2013-03-03 |
| 0781-5422-92 | EA - Each | 0781-5422 | 8b90c154-39ad-48be-8230-2b9190f33f72 | 1 | 2013-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE | ACTIVE INGREDIENT | JQT35NPK6C | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| PIOGLITAZONE | ACTIVE MOIETY | X4OV71U42S | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | PIOGLITAZONE TABLET [SANDOZ INC] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PIOGLITAZONE TABLET [SANDOZ INC] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pioglitazone and metformin hydrochloride | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 8080eedb-e955-4059-98b2-9685b608eb3e | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Chartwell RX, LLC | 699e865a-952e-459e-a871-9b7cce475b71 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Alogliptin and Pioglitazone | ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 642b1e90-701e-42f2-bac6-a4918738e2c9 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Bryant Ranch Prepack | c9548800-4c44-473d-a89b-c705484548b3 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | 6397fb4c-081b-4abd-ab4b-0a3fbf99e663 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Aurobindo Pharma Limited | 1f259863-21fd-4d62-b094-4eff845944df | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | QUALLENT PHARMACEUTICALS HEALTH LLC | 0331400c-b163-4856-bfb0-965470247cb3 | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Rising Pharma Holdings, Inc. | 4483b1c6-7095-4a63-8128-ac2d91e11040 | 2025-05-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazole and metformin hydrochloride | PIOGLITAZOLE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | 7418254e-7232-466f-9d6b-4743b0bba2a1 | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazole and metformin hydrochloride | PIOGLITAZOLE AND METFORMIN HYDROCHLORIDE | Bryant Ranch Prepack | bd9c05c9-278f-498d-881c-29ba1b60596e | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Actos | PIOGLITAZONE | Takeda Pharmaceuticals America, Inc. | d2ddc491-88a9-4063-9150-443b4fa4330c | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Duetact | PIOGLITAZONE AND GLIMEPIRIDE | Takeda Pharmaceuticals America, Inc. | f8b0c917-3fdd-4a28-a47d-6225b8195458 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE HYDROCHLORIDE | PIOGLITAZONE HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | 31619517-a590-408a-ae9e-76c99f0a0a1d | 2025-03-05 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| OSENI | ALOGLIPTIN AND PIOGLITAZONE | Takeda Pharmaceuticals America, Inc. | 4c619ed9-fe3e-4158-9938-80c6c3493d55 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 8d252dab-e868-42d3-95ea-69423d909e84 | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| PIOGLITAZONE | PIOGLITAZONE | DIRECT RX | a7e8d5a3-b0da-1d70-e053-2a95a90aa435 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | bde7fa79-aafc-3ba0-e053-2a95a90aa4d2 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | Bryant Ranch Prepack | f6cad01e-cd65-4c8d-9e49-399404f22005 | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | af863b9e-9646-3b1e-e053-2995a90ab93a | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
| Pioglitazone | PIOGLITAZONE | NuCare Pharmaceuticals,Inc. | a4751cb4-0700-dd22-e053-2995a90adfdb | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | JQT35NPK6C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.